Protecting Life from Chemical Abortions Act

Reinstatement of In-Person Dispensing: The bill reinstates the requirement that abortion drugs be dispensed only in clinics, medical offices, and hospitals under the supervision of a certified health care provider (Section 3(a)(2)).

Protection of Current Drug Strategies: The bill prevents officials from reducing protections within the risk evaluation and mitigation strategy for abortion drugs until certain data requirements are met (Section 3(b)(1)).

Standardized Data Collection: The bill requires the collection of specific data points—such as maternal age, race, ethnicity, and gestational age—to be submitted to the CDC's abortion surveillance system (Section 3(b)(1) and Section 3(c)).

Prohibition of Public Health Emergency Declarations: The Secretary of Health and Human Services is prohibited from using or declaring a public health emergency with respect to abortion (Section 2(a)).

Termination of Existing Declarations: Any public health emergency declaration regarding abortion that is currently in effect will be terminated upon the enactment of this Act (Section 2(b)).

Strict Requirements for Drug Dispensing: Officials are prohibited from waiving the requirement that abortion drugs be dispensed only in specific medical settings under the supervision of a certified health care provider (Section 3(b)(2)).

Specific Provider Qualifications: To be considered a "certified health care provider" for these drugs, the provider must have specific abilities, such as diagnosing ectopic pregnancies and providing surgical intervention or arranging access to medical facilities for blood transfusions and resuscitation (Section 3(d)(3)).